Prescription Dermatology Therapeutics Market - Overview
This report by Transparency Market Research analyzes the global prescription dermatology therapeutics market for the period between 2018 and 2026.An in-depth and unbiased market assessment has been made which offers readers an in-depth and accurate analysis.
Market projections have been offered in terms of value (US$ Mn). Stakeholders of this report include companies and intermediaries engaged in research & development, manufacture, and marketing of products prescribed in the treatment of various skin conditions.
The global prescription dermatology therapeutics market has been studied for the forecast period from 2018 to 2026.For research, 2017 has been considered as the base year and 2016 as the historical year.
The global prescription dermatology therapeutics market report comprises an elaborate executive summary that provides overall information about various segments of the market.The report provides a detailed competitive landscape, by major players operating in this market along with their shares (value %) of the global prescription dermatology therapeutics market for 2017.
The report also provides detailed company profiles of emerging market players operating in the global prescription dermatology therapeutics market.
The market overview section comprises impact factors such as key market dynamics including drivers, restraints, and opportunities, affecting the global prescription dermatology therapeutics market.These factors are likely to aid stakeholders establish a strong foothold in the global prescription dermatology therapeutics market.
Furthermore, the market overview section comprises key industry events, pipeline analysis, key mergers & acquisitions across the dermatology industry, epidemiology analysis of the skin diseases, product portfolio overview of leading players, and market attractiveness analysis in the global prescription dermatology therapeutics market. The market attractiveness analysis provides a graphical view comparing the expansion and market dynamics in various segments and countries to identify the most attractive market.
Scope
The global prescription dermatology therapeutics market has been segmented based product type, distribution channel, and region.In terms of product type, the global market has been classified into acne & rosacea drugs, psoriasis drugs, dermatitis & seborrhea drugs, fungal infection drugs, skin cancer, and others.
In terms of distribution channel, the global prescription dermatology therapeutics market has been categorized into hospital pharmacies, retail pharmacies, and mail order pharmacies.
In terms of region, the global prescription dermatology therapeutics market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Moreover, quantitative analysis for major countries comprising the U.S., Canada, Germany, France, the U.K., Italy, Spain, Russia, China, Japan, India, and Australia & New Zealand has also been provided in the report. A detailed qualitative analysis of factors responsible for driving and restraining the global market in various regions has been provided in this section.
The report provides a detailed outline/blueprint of the global prescription dermatology therapeutics market which is expected to assist new companies establish their presence and companies to expand their share in the market. The report concludes with the company profiles section, which includes company overview, financial overview, SWOT analysis, product portfolio, business strategies, and recent developments of key players.
Competitive landscape
Major players operating in the global prescription dermatology therapeutics market include AbbVie, Inc., Janssen Biotech, Inc., Novartis AG, Amgen, Inc., Celgene Corporation, Pfizer, Inc., LEO Pharma A/S, Eli Lilly and Company, Bausch Health Companies, Inc., Sun Pharmaceuticals Ltd., Aclaris Therapeutics, Inc., and Aurobindo Pharma Ltd.
The global prescription dermatology therapeutics market has been segmented into:
Global Prescription Dermatology Therapeutics Market, by Product Type
Acne & Rosacea Drugs
Psoriasis Drugs
Dermatitis & Seborrhea Drugs
Fungal Infection Drugs
Skin Cancer Drugs
Others
Global Prescription Dermatology Therapeutics Market, by Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Mail Order Pharmacies
Global Prescription Dermatology Therapeutics Market, by Region
North America
U.S.
Canada
Europe
Germany
France
Italy
U.K.
Spain
Rest of Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of Middle East & Africa